Discrepant serum creatinine concentrations caused by paraprotein interference preceding diagnosis of monoclonal gammopathy of undetermined significance

被引:1
作者
Kobara, Miyuki [1 ,2 ]
Inaba, Tohru [3 ]
Matoba, Satoaki [2 ]
Nakata, Tetsuo [1 ,2 ]
机构
[1] Kyoto Pharmaceut Univ, Clin Pharmacol, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Infect Control & Lab Med, Kyoto, Japan
关键词
General practice / family medicine; Haematology (incl blood transfusion); Medical management; MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; FOLLOW-UP; PROGRESSION; CRITERIA; PATIENT; DISEASE;
D O I
10.1136/bcr-2023-256242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a man in his 70s who presented with discrepant serum creatinine concentrations in different hospitals at the same time. Further examinations of these discrepancies revealed turbidity of the serum sample and, thus, a reagent reaction and false hypercreatinine caused by paraprotein interference were suspected. Serum protein electrophoresis revealed a small amount of monoclonal gamma globulin (2.9 g/L), which may have been involved in paraprotein interference. Monoclonal lambda-type IgG was detected in the serum, resulting in a diagnosis of monoclonal gammopathy of undetermined significance. Previous studies indicated paraprotein interference in serum containing monoclonal IgM or a large amount of IgG (> 25 g/L). Although this case of paraprotein interference induced by a small amount of IgG is rare, a discrepancy in creatinine results may be an indicator leading to the diagnosis of plasma cell proliferative diseases.
引用
收藏
页数:4
相关论文
共 26 条
  • [1] Monoclonal gammopathy of undetermined significance: a consensus statement
    Berenson, James R.
    Anderson, Kenneth C.
    Audell, Robert A.
    Boccia, Ralph V.
    Coleman, Morton
    Dimopoulos, Meletios A.
    Drake, Matthew T.
    Fonseca, Rafael
    Harousseau, Jean-Luc
    Joshua, Douglas
    Lonial, Sagar
    Niesvizky, Ruben
    Palumbo, Antonio
    Roodman, G. David
    San-Miguel, Jesus F.
    Singhal, Seema
    Weber, Donna M.
    Zangari, Maurizio
    Wirtschafter, Eric
    Yellin, Ori
    Kyle, Robert A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 28 - 38
  • [2] Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients
    Bida, John P.
    Kyle, Robert A.
    Therneau, Terry M.
    Melton, L. Joseph, III
    Plevak, Matthew F.
    Larson, Dirk R.
    Dispenzieri, Angela
    Katzmann, Jerry A.
    Rajkumar, S. Vincent
    [J]. MAYO CLINIC PROCEEDINGS, 2009, 84 (08) : 685 - 693
  • [3] DATTA P, 1986, AM J CLIN PATHOL, V85, P463, DOI 10.1093/ajcp/85.4.463
  • [4] Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER-Medicare Population Analysis
    Go, Ronald S.
    Gundrum, Jacob D.
    Neuner, Joan M.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (03) : 177 - 186
  • [5] Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma
    Goyal, Gaurav
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Dispenzieri, Angela
    Hwa, Yi L.
    Fonder, Amie L.
    Hobbs, Miriam A.
    Hayman, Suzanne R.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis V.
    Warsame, Rahma
    Kyle, Robert A.
    Kumar, Shaji K.
    [J]. LEUKEMIA, 2019, 33 (05) : 1273 - 1277
  • [6] HOLMES EW, 1983, ANN CLIN LAB SCI, V13, P503
  • [7] Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenstrom's macroglobulinemia
    Hummel, KM
    von Ahsen, N
    Kühn, RB
    Kaboth, U
    Grunewald, RW
    Oellerich, M
    Müller, GA
    [J]. NEPHRON, 2000, 86 (02): : 188 - 189
  • [8] Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
    Kyle, R. A.
    Durie, B. G. M.
    Rajkumar, S. V.
    Landgren, O.
    Blade, J.
    Merlini, G.
    Kroeger, N.
    Einsele, H.
    Vesole, D. H.
    Dimopoulos, M.
    San Miguel, J.
    Avet-Loiseau, H.
    Hajek, R.
    Chen, W. M.
    Anderson, K. C.
    Ludwig, H.
    Sonneveld, P.
    Pavlovsky, S.
    Palumbo, A.
    Richardson, P. G.
    Barlogie, B.
    Greipp, P.
    Vescio, R.
    Turesson, I.
    Westin, J.
    Boccadoro, M.
    [J]. LEUKEMIA, 2010, 24 (06) : 1121 - 1127
  • [9] Kyle RA, 2003, BRIT J HAEMATOL, V121, P749
  • [10] A long-term study of prognosis in monoclonal gammopathy of undetermined significance
    Kyle, RA
    Therneau, TM
    Rajkumar, SV
    Offord, JR
    Larson, DR
    Plevak, MF
    Melton, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) : 564 - 569